var data={"title":"Nervus intermedius neuralgia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Nervus intermedius neuralgia</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/contributors\" class=\"contributor contributor_credentials\">Ivan Garza, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/contributors\" class=\"contributor contributor_credentials\">Jerry W Swanson, MD, MHPE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/contributors\" class=\"contributor contributor_credentials\">John F Dashe, MD, PhD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 22, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION AND DEFINITION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neuralgia is a form of neuropathic pain that is characterized by the following features [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/1-3\" class=\"abstract_t\">1-3</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Paroxysmal, brief (seconds to a few minutes), shock-like or lightning-like pain that follows a peripheral or cranial nerve distribution and can spread to adjacent areas in the course of the attack.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>By definition, no objective neurologic deficits are found in the distribution of the affected nerve. (See <a href=\"topic.htm?path=overview-of-craniofacial-pain\" class=\"medical medical_review\">&quot;Overview of craniofacial pain&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Attacks can be provoked by nonpainful stimulation (allodynia) of trigger points or zones.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A refractory period follows attacks; the duration of the refractory period shortens as the disease progresses.</p><p/><p>Nervus intermedius neuralgia is a rare disorder characterized by brief paroxysms of pain felt deeply in the auditory canal [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/4\" class=\"abstract_t\">4</a>]. Other terms previously used for this condition used are geniculate neuralgia and Hunt neuralgia [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/5\" class=\"abstract_t\">5</a>].</p><p>This topic will review clinical aspects of nervus intermedius neuralgia. Other cranial neuralgias and central causes of facial pain are discussed separately. (See <a href=\"topic.htm?path=overview-of-craniofacial-pain\" class=\"medical medical_review\">&quot;Overview of craniofacial pain&quot;</a> and <a href=\"topic.htm?path=central-neuropathic-facial-pain\" class=\"medical medical_review\">&quot;Central neuropathic facial pain&quot;</a> and <a href=\"topic.htm?path=cold-stimulus-headache\" class=\"medical medical_review\">&quot;Cold stimulus headache&quot;</a> and <a href=\"topic.htm?path=nummular-headache\" class=\"medical medical_review\">&quot;Nummular headache&quot;</a> and <a href=\"topic.htm?path=occipital-neuralgia\" class=\"medical medical_review\">&quot;Occipital neuralgia&quot;</a> and <a href=\"topic.htm?path=trigeminal-neuralgia\" class=\"medical medical_review\">&quot;Trigeminal neuralgia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">ANATOMY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The intermediate nerve of Wrisberg (the nervus intermedius) is a small sensory branch of the facial nerve (cranial nerve VII) carrying general visceral efferent, special visceral afferent (taste), and general somatic afferent fibers (<a href=\"image.htm?imageKey=NEURO%2F68923\" class=\"graphic graphic_figure graphicRef68923 \">figure 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/5,6\" class=\"abstract_t\">5,6</a>]. The cell bodies of the sensory afferents dwell in the geniculate ganglion, and their peripheral axons innervate the inner ear, the middle ear, the mastoid cells, the eustachian tube, and part of the pinna of the ear [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/5,7\" class=\"abstract_t\">5,7</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is no proven pathologic substrate for nervus intermedius neuralgia [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/7\" class=\"abstract_t\">7</a>]. In addition, there is no indisputable evidence that the neuralgic pain originates in the geniculate ganglion or the nervus intermedius.</p><p>Some investigators believe that compression of the nerve by a blood vessel is an important mechanism [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/8,9\" class=\"abstract_t\">8,9</a>], and relief of pain by vascular decompression of the intermediate nerve provides some support for this position [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/8\" class=\"abstract_t\">8</a>]. However, there are multiple cranial nerve afferents in the ear [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/10\" class=\"abstract_t\">10</a>], and otalgia in these cases could have resulted from a compromise to the nervus intermedius, <span class=\"nowrap\">and/or</span> cranial nerves VII, VIII, and other cranial nerves. In different surgical reports, section or decompression of a combination of cranial nerves V, VII, VIII, IX, X, <span class=\"nowrap\">and/or</span> XI has been necessary to obtain relief [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/1,5\" class=\"abstract_t\">1,5</a>]. Thus, the role of vascular compression in the pathogenesis of geniculate and other neuralgias is disputed [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nervus intermedius neuralgia is rare, and only limited data are available regarding the incidence, prevalence, and risk factors associated with this condition. Middle-aged women are predominantly affected, as found in a systematic review of the literature published in 2013 [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/12\" class=\"abstract_t\">12</a>]. Of the identified 15 cases of surgically validated nervus intermedius neuralgia, women accounted for 14 (93 percent), and the median age at symptom onset was 41 years (range 16 to 47 years).</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The syndrome consists of brief (usually lasting seconds, rarely minutes), severe paroxysmal pain, felt within the depths of the ear, and occasionally associated with a trigger-zone in the posterior wall of the ear canal. The pain can be sharp or burning, and sometimes radiates from the auditory canal to the parieto-occipital region or to trigeminal sensory zones [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/12\" class=\"abstract_t\">12</a>]. Altered taste perception, such as a sense of bitter taste, can occur in some individuals, as can disorders of lacrimation or salivation [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/1,4,7\" class=\"abstract_t\">1,4,7</a>].</p><p>The presence of an attack trigger (ie, auditory canal stimulation) was once considered a characteristic feature of nervus intermedius neuralgia. However, a systematic review found that a trigger was described in only 3 of 10 patients with available data [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/12\" class=\"abstract_t\">12</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of nervus intermedius neuralgia is made on clinical grounds and is based upon pain description. The diagnosis requires ruling out other neurologic and otolaryngologic causes of ear pain [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/5\" class=\"abstract_t\">5</a>].</p><p>The diagnosis of classic nervus intermedius neuralgia, according to the International Classification of Headache Disorders 3rd edition (ICHD-3), requires fulfilling all of the following criteria [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/4\" class=\"abstract_t\">4</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>At least three attacks of unilateral pain</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The pain is located in the auditory canal, sometimes radiating to the parieto-occipital region</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The pain has at least three of the following four characteristics:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Recurring in paroxysmal attacks lasting from a few seconds to minutes</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Severe intensity</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Shooting, stabbing or sharp in quality</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Precipitated by stimulation of a trigger area in the posterior wall of the auditory canal <span class=\"nowrap\">and/or</span> periauricular region</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>No clinically evident neurological deficit</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Not better accounted for by another ICHD-3 diagnosis</p><p/><p>The condition is rare if one carefully adheres to these criteria.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Differential</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some patients fitting into the above diagnostic criteria may have a variant of glossopharyngeal neuralgia with pain paroxysms restricted to the ear [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/12\" class=\"abstract_t\">12</a>]. This is the main disorder in the differential diagnosis. In such cases, the typical pharyngeal pain of glossopharyngeal neuralgia may not occur until years later [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/1\" class=\"abstract_t\">1</a>]. (See <a href=\"topic.htm?path=overview-of-craniofacial-pain#H6\" class=\"medical medical_review\">&quot;Overview of craniofacial pain&quot;, section on 'Glossopharyngeal neuralgia'</a>.)</p><p>In a few case reports, vascular compression of cranial nerve VII, the intermediate nerve, and cranial nerve VIII by a loop of the anterior inferior cerebellar artery was identified as the cause of intractable paroxysmal ear pain. One patient also had ipsilateral sensorineural hearing loss, tinnitus, and positional vertigo [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/8\" class=\"abstract_t\">8</a>]; another had hemifacial spasm [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/9\" class=\"abstract_t\">9</a>].</p><p>Secondary nervus intermedius neuropathy is most commonly caused by reactivation of latent varicella-zoster virus (ie, herpes zoster) within the geniculate ganglion, with subsequent spread of inflammation to nearby ganglia and cranial nerves, leading to ear pain, ipsilateral facial paresis, and vesicular eruption in the auditory canal and auricle (ie, the Ramsay Hunt syndrome). (See <a href=\"topic.htm?path=clinical-manifestations-of-varicella-zoster-virus-infection-herpes-zoster#H15\" class=\"medical medical_review\">&quot;Clinical manifestations of varicella-zoster virus infection: Herpes zoster&quot;, section on 'Ramsay Hunt syndrome (Herpes zoster oticus)'</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As noted above, it is necessary to rule out other neurologic, otolaryngologic, and infectious causes of ear pain in cases of suspected nervus intermedius neuralgia.</p><p>The workup requires a contrast-enhanced MRI of the brain, focusing on the internal auditory meatus. Brain MRI is useful for identifying structural brain lesions (eg, demyelinating lesions or a mass lesion in the cerebellopontine angle). Magnetic resonance angiography (MRA) is useful for demonstrating an ectatic blood vessel compressing the nerve. However, the sensitivity and specificity of these imaging studies for identifying a secondary cause of ear pain in patients with suspected nervus intermedius neuralgia and a normal neurologic examination is unknown.</p><p>We recommend a brain MRI (contrast-enhanced) and MRA for patients with suspected classic nervus intermedius neuralgia to rule out a structural lesion or vascular compression. Urgent brain imaging is warranted if there are neurologic deficits.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The rarity of nervus intermedius neuralgia has precluded accumulation of data that could guide therapy [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/5,7\" class=\"abstract_t\">5,7</a>]. Pharmacologic treatment is based largely upon extrapolation from treatments that are effective for other cranial neuralgias, mainly trigeminal neuralgia. (See <a href=\"topic.htm?path=trigeminal-neuralgia#H12\" class=\"medical medical_review\">&quot;Trigeminal neuralgia&quot;, section on 'Medical therapy'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Pharmacotherapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>As with trigeminal neuralgia, a trial of <a href=\"topic.htm?path=carbamazepine-drug-information\" class=\"drug drug_general\">carbamazepine</a> is reasonable for patients with nervus intermedius neuralgia. The usual starting dose of carbamazepine is 100 to 200 mg twice daily. The dose can be increased slowly over several weeks as needed for pain relief, with a typical maintenance dose of 600 to 1200 mg daily.</p><p>Adverse effects of <a href=\"topic.htm?path=carbamazepine-drug-information\" class=\"drug drug_general\">carbamazepine</a> include drowsiness, dizziness, nausea, and vomiting; slow titration may minimize these effects. Carbamazepine-induced leukopenia is not uncommon, but it is usually benign. Aplastic anemia is a rare side effect. The Stevens-Johnson syndrome and toxic epidermal necrolysis are additional rare complications, particularly during the first eight weeks of therapy. They are significantly more common (estimated incidence of 5 percent) among patients with the HLA-B*1502 allele. This allele occurs almost exclusively in patients of Asian ancestry, including South Asian Indians. Screening for this allele is recommended in patients of these ethnic groups prior to starting carbamazepine. (See <a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis#H20\" class=\"medical medical_review\">&quot;Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Genetic factors'</a> and <a href=\"topic.htm?path=antiseizure-drugs-mechanism-of-action-pharmacology-and-adverse-effects#H3\" class=\"medical medical_review\">&quot;Antiseizure drugs: Mechanism of action, pharmacology, and adverse effects&quot;, section on 'Carbamazepine'</a>.)</p><p>For patients who do not tolerate or respond to <a href=\"topic.htm?path=carbamazepine-drug-information\" class=\"drug drug_general\">carbamazepine</a>, alternative drugs include <a href=\"topic.htm?path=oxcarbazepine-drug-information\" class=\"drug drug_general\">oxcarbazepine</a>, <a href=\"topic.htm?path=gabapentin-drug-information\" class=\"drug drug_general\">gabapentin</a>, <a href=\"topic.htm?path=phenytoin-drug-information\" class=\"drug drug_general\">phenytoin</a>, <a href=\"topic.htm?path=lamotrigine-drug-information\" class=\"drug drug_general\">lamotrigine</a>, and <a href=\"topic.htm?path=baclofen-drug-information\" class=\"drug drug_general\">baclofen</a>. In addition, tricyclics (eg, <a href=\"topic.htm?path=amitriptyline-drug-information\" class=\"drug drug_general\">amitriptyline</a>) and <a href=\"topic.htm?path=pregabalin-drug-information\" class=\"drug drug_general\">pregabalin</a> are useful in other types of neuropathic pain. In clinical practice, however, tricyclic medications are only occasionally effective.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Surgery</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neurosurgery is considered as a last resort when pharmacotherapy fails or when adverse effects of medications significantly reduce quality of life.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most often, the procedure involves excision of the nervus intermedius and geniculate ganglion [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/13\" class=\"abstract_t\">13</a>], with or without exploration <span class=\"nowrap\">and/or</span> section of cranial nerves V, IX, and X [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/14\" class=\"abstract_t\">14</a>]. The surgeon may elect to perform vascular decompression if a potential offending vessel is seen during exploration. One series of 64 patients who had excision of the nervus intermedius and geniculate ganglion reported &quot;excellent&quot; results in 63 patients, but outcomes were not objectively defined in this report [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/13\" class=\"abstract_t\">13</a>]. Complications included a temporary partial facial paralysis in 11 patients (17 percent). In addition, permanent ipsilateral xerophthalmia is an expected outcome, due to sectioning of the greater petrosal nerve as part of the surgical approach to the geniculate ganglion.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Microvascular decompression of cranial nerves V, IX, and X, with or without section of the nervus intermedius, is another option [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/15\" class=\"abstract_t\">15</a>]. In a series of 10 patients with nervus intermedius neuralgia treated with microvascular decompression who had long-term (&gt;12 months) follow-up, an &quot;excellent&quot; outcome was reported for three patients, and partial relief for six [<a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/16\" class=\"abstract_t\">16</a>].</p><p/><p class=\"headingAnchor\" id=\"H944108247\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-cranial-neuralgias-and-central-causes-of-facial-pain\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Cranial neuralgias and central causes of facial pain&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nervus intermedius neuralgia is a rare disorder characterized by brief paroxysms of pain felt deeply in the auditory canal. Middle aged women are predominantly affected. (See <a href=\"#H1\" class=\"local\">'Introduction and definition'</a> above and <a href=\"#H4\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The symptoms of nervus intermedius neuralgia consist of episodes of brief (seconds to minutes), severe paroxysmal pain, felt in the depths of the ear, sometimes radiating to the parieto-occipital region or trigeminal sensory zones, and occasionally triggered by stimulation in the posterior wall of the ear canal. The pain can be sharp or burning. (See <a href=\"#H5\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of nervus intermedius neuralgia is made on clinical grounds and is based upon pain description. The diagnosis requires ruling out other neurologic and otolaryngologic causes of ear pain. (See <a href=\"#H6\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The differential diagnosis includes atypical presentations of glossopharyngeal neuralgia with pain paroxysms restricted to the ear, as well as vascular compression of cranial nerves VII, VIII, and the intermediate nerve. Secondary nervus intermedius neuropathy is most commonly caused by herpes zoster. (See <a href=\"#H7\" class=\"local\">'Differential'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with suspected classic nervus intermedius neuralgia, we recommend a contrast-enhanced brain MRI and MRA to rule out a structural lesion or vascular compression. (See <a href=\"#H8\" class=\"local\">'Evaluation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with classic nervus intermedius neuralgia, we suggest initial treatment with <a href=\"topic.htm?path=carbamazepine-drug-information\" class=\"drug drug_general\">carbamazepine</a>&nbsp;(<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Alternatives include <a href=\"topic.htm?path=oxcarbazepine-drug-information\" class=\"drug drug_general\">oxcarbazepine</a>, <a href=\"topic.htm?path=gabapentin-drug-information\" class=\"drug drug_general\">gabapentin</a>, <a href=\"topic.htm?path=pregabalin-drug-information\" class=\"drug drug_general\">pregabalin</a>, <a href=\"topic.htm?path=phenytoin-drug-information\" class=\"drug drug_general\">phenytoin</a>, <a href=\"topic.htm?path=lamotrigine-drug-information\" class=\"drug drug_general\">lamotrigine</a>, <a href=\"topic.htm?path=baclofen-drug-information\" class=\"drug drug_general\">baclofen</a>, and tricyclic drugs such as <a href=\"topic.htm?path=amitriptyline-drug-information\" class=\"drug drug_general\">amitriptyline</a>. Neurosurgical treatment is an option if pharmacotherapy fails. (See <a href=\"#H9\" class=\"local\">'Treatment'</a> above.)</p><p/><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/1\" class=\"nounderline abstract_t\">Bruyn GW. Nervus intermedius neuralgia (Hunt). Cephalalgia 1984; 4:71.</a></li><li class=\"breakAll\">Peter C, Watson N. Trigeminal neuropathy and neuralgia. In: Neurological therapeutics: Principles and practice, Noseworthy JH (Ed), Martin Dunitz, London, New York 2003. p.1849.</li><li class=\"breakAll\">Goodwin JG, Bajwa ZH. Understanding the patient with chronic pain. In: Principles and practice of pain medicine, Bajwa ZH (Ed), McGraw-Hill, Warfield, CA 2004. p.55.</li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/4\" class=\"nounderline abstract_t\">Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33:629.</a></li><li class=\"breakAll\">Nurmikko TJ, Jensen TS. Trigeminal neuralgia and other facial neuralgias. In: The headaches, Olesen J, Goadsby PJ, et al (Eds), Lippincott Williams and Wilkins, Philadelphia 2006. Vol 1053.</li><li class=\"breakAll\">Nurmikko TJ, Jensen TS. Trigeminal neuralgia and other facial neuralgias. In: The headaches, Olesen J, Goadsby PJ, et al (Eds), Lippincott Williams and Wilkins, Philadelphia 2006. p.1053.</li><li class=\"breakAll\">Boes CJ, Copobianco DJ, Cutrer FM, et al. Headache and other craniofacial pain. In: Neurology in clinical practice, Bradley WG, Daroff RB, Fenichel GM, et al (Eds), Butterworth Heinemann, Philadelphia 2004. p.2055.</li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/8\" class=\"nounderline abstract_t\">Sakas DE, Panourias IG, Stranjalis G, et al. Paroxysmal otalgia due to compression of the intermediate nerve: a distinct syndrome of neurovascular conflict confirmed by neuroimaging. Case report. J Neurosurg 2007; 107:1228.</a></li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/9\" class=\"nounderline abstract_t\">Yeh HS, Tew JM Jr. Tic convulsif, the combination of geniculate neuralgia and hemifacial spasm relieved by vascular decompression. Neurology 1984; 34:682.</a></li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/10\" class=\"nounderline abstract_t\">Shah RK, Blevins NH. Otalgia. Otolaryngol Clin North Am 2003; 36:1137.</a></li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/11\" class=\"nounderline abstract_t\">Monstad P. Microvascular decompression as a treatment for cranial nerve hyperactive dysfunction--a critical view. Acta Neurol Scand Suppl 2007; 187:30.</a></li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/12\" class=\"nounderline abstract_t\">Smith JH, Robertson CE, Garza I, Cutrer FM. Triggerless neuralgic otalgia: a case series and systematic literature review. Cephalalgia 2013; 33:914.</a></li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/13\" class=\"nounderline abstract_t\">Pulec JL. Geniculate neuralgia: long-term results of surgical treatment. Ear Nose Throat J 2002; 81:30.</a></li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/14\" class=\"nounderline abstract_t\">Rupa V, Saunders RL, Weider DJ. Geniculate neuralgia: the surgical management of primary otalgia. J Neurosurg 1991; 75:505.</a></li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/15\" class=\"nounderline abstract_t\">Inoue T, Shima A, Hirai H, et al. Nervus Intermedius Neuralgia Treated with Microvascular Decompression: A Case Report and Review of the Literature. NMC Case Rep J 2017; 4:75.</a></li><li><a href=\"https://www.uptodate.com/contents/nervus-intermedius-neuralgia/abstract/16\" class=\"nounderline abstract_t\">Lovely TJ, Jannetta PJ. Surgical management of geniculate neuralgia. Am J Otol 1997; 18:512.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 3331 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H12\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION AND DEFINITION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">ANATOMY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">PATHOPHYSIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">EPIDEMIOLOGY</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">DIAGNOSIS</a><ul><li><a href=\"#H7\" id=\"outline-link-H7\">Differential</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Evaluation</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">TREATMENT</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">Pharmacotherapy</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Surgery</a></li></ul></li><li><a href=\"#H944108247\" id=\"outline-link-H944108247\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"NEURO/3331|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=NEURO/68923\" class=\"graphic graphic_figure\">- Nervus intermedius</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antiseizure-drugs-mechanism-of-action-pharmacology-and-adverse-effects\" class=\"medical medical_review\">Antiseizure drugs: Mechanism of action, pharmacology, and adverse effects</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=central-neuropathic-facial-pain\" class=\"medical medical_review\">Central neuropathic facial pain</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-varicella-zoster-virus-infection-herpes-zoster\" class=\"medical medical_review\">Clinical manifestations of varicella-zoster virus infection: Herpes zoster</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cold-stimulus-headache\" class=\"medical medical_review\">Cold stimulus headache</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nummular-headache\" class=\"medical medical_review\">Nummular headache</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=occipital-neuralgia\" class=\"medical medical_review\">Occipital neuralgia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-craniofacial-pain\" class=\"medical medical_review\">Overview of craniofacial pain</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-cranial-neuralgias-and-central-causes-of-facial-pain\" class=\"medical medical_society_guidelines\">Society guideline links: Cranial neuralgias and central causes of facial pain</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=stevens-johnson-syndrome-and-toxic-epidermal-necrolysis-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Stevens-Johnson syndrome and toxic epidermal necrolysis: Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=trigeminal-neuralgia\" class=\"medical medical_review\">Trigeminal neuralgia</a></li></ul></div></div>","javascript":null}